Proteins with Improved Solubility and Methods for Producing and Using Same
OwnerClifford C. Shone, James A. Crawfordinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerClifford C. Shone, James A. Crawfordinventors
Estimating the term…
A method is provided for improving the solubility of proteins, for example, bacterial toxins. In one embodiment, solubility is improved by introducing point mutations that replace cysteine residues capable of forming intermolecular disulfide bonds with other amino acid residues that do not form such bonds. By abrogating the ability of the cysteine residues to form inter-molecular disulfide bonds, aggregation of the protein is reduced, thereby improving the solubility of the protein. In another embodiment, solubility of the protein is improved by producing truncated forms of the protein that express the LHN domain and a fragment of the Hc domain. Proteins made according to the method of the invention are useful, for example, as immunodiagnostic agents and vaccine components.
1-34. (canceled)
A recombinant protein comprising a truncated botulinum serotype E toxin, wherein the truncation improves the solubility of the recombinant protein.
A method for improving the solubility of a clostridial neurotoxin, comprising:
A mutated botulinum serotype E toxin comprising either or both of a leucine residue substituted for the tryptophan residue at position 1223 and a phenylalanine residue for the tyrosine residue at position 1224 of SEQ ID NO:
53-58. (canceled)
Dependencies are inferred from the claim text.